HbA1c検査の世界市場：動向、予測、競合分析（～2030年）

HbA1c検査の動向と予測

世界のHbA1c検査の市場規模は、2024～2030年にかけてCAGR 12.5%で成長し、2030年までに推定34億米ドルに達すると予測されます。この市場の主な促進要因は、糖尿病の罹患率の増加と血糖コントロールに関する意識の高まりです。世界のHbA1c検査市場の将来は、病院・クリニック、診断検査機関、在宅医療、研究機関の各市場における機会によって有望視されています。

HbA1c検査市場の洞察

Lucintelの予測では、正確な結果が得られ費用対効果も高い比濁阻害免疫測定法は、予測期間中に最も高い成長が見込まれます。

同市場では、老年人口の増加により、病院・診療所が最大セグメントであり続けると考えられます。

研究や啓蒙キャンペーンなどの活動の増加により、予測期間中も最大の地域であり続けると思われます。

よくある質問

Q1.市場規模は？

A1.世界のHbA1c検査市場は、2030年までに推定34億米ドルに達すると予想されています。

Q2.市場の成長予測は？

A2.世界のHbA1c検査市場は、2024～2030年にかけてCAGR 12.5%で成長すると予測されます。

Q3.市場の成長に影響を与える主な促進要因は？

A3.この市場の主な促進要因は、糖尿病の罹患率の増加と血糖コントロールに関する意識の高まりです。

Q4.市場の主要セグメントは？

A4.HbA1c検査市場の将来性は、病院・診療所、診断ラボ、在宅医療、研究機関の各市場における機会により有望視されています。

Q5.市場の主要企業は？

A5.HbA1c検査の主要企業は以下の通りです。

• Abbott
• Bio-Rad Laboratories
• ARKRAY
• Danaher
• F. Hoffmann-La Roche

Q6.今後、最大となる市場セグメントは？

A6.Lucintelの予測では、正確な結果が得られ費用対効果も高い比濁阻害免疫測定法が、予測期間中に最も高い成長を遂げる見込みです。

Q7.市場において、今後5年間に最大になると予想される地域は？

A7.北米は、同地域における研究や啓蒙キャンペーンなどの活動の増加により、予測期間中も最大の地域であり続けると思われます。

Q8.レポートのカスタマイズは可能？

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界のHbA1c検査市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析（2018～2030年）

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界のHbA1c検査の市場動向（2018～2023年）と予測（2024～2030年）
• 世界のHbA1c検査市場：タイプ別
  • 機器
  • 試薬
  • キット
• 世界のHbA1c検査市場：技術別
  • イオン交換HPLC
  • 酵素アッセイ
  • 親和性結合クロマトグラフィー
  • 比濁阻害免疫測定法
  • その他
• 世界のHbA1c検査市場：最終用途別
  • 病院・診療所
  • 診断研究所
  • ホームケア
  • 研究機関
  • その他

第4章 市場動向と予測分析：地域別（2018～2030年）

• 世界のHbA1c検査市場：地域別
• 北米
• 欧州
• アジア太平洋
• その他の地域

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • タイプ別
  • 技術別
  • 最終用途別
  • 地域別
• 世界のHbA1c検査市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のHbA1c検査市場の能力拡大
  • 世界のHbA1c検査市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Abbott
• Bio-Rad Laboratories
• ARKRAY
• Danaher
• F. Hoffmann-La Roche

HbA1c Testing Trends and Forecast

The future of the global HbA1c testing market looks promising with opportunities in the hospital &clinic, diagnostic laboratorie, homecare, and research institution markets. The global HbA1c testing market is expected to reach an estimated $3.4 billion by 2030 with a CAGR of 12.5% from 2024 to 2030. The major drivers for this market are growing incidence of diabetes and increasing awareness regarding glycemic control.

A more than 150-page report is developed to help in your business decisions.

HbA1c Testing by Segment

The study includes a forecast for the global HbA1c testing by type, technology, end use, and region.

HbA1c Testing Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Instruments
• Reagents
• Kits

HbA1c Testing Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• Ion-Exchange HPLC
• Enzymatic Assay
• Affinity Binding Chromatography
• Turbidimetric Inhibition Immunoassay
• Others

HbA1c Testing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals and Clinics
• Diagnostic Laboratories
• Homecare
• Research Institution
• Others

HbA1c Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of HbA1c Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies HbA1c testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the HbA1c testing companies profiled in this report include-

• Abbott
• Bio-Rad Laboratories
• ARKRAY
• Danaher
• F. Hoffmann-La Roche

HbA1c Testing Market Insights

Lucintel forecasts that turbidimetric inhibition immunoassay is expected to witness the highest growth over the forecast period as it delivers accurate results and are cost effective.

Within this market, hospital & clinic will remain the largest segment due to growing geriatric population.

North America will remain the largest region over the forecast period due to increase in number of activities like esearch and awareness campaigns in the region.

Features of the Global HbA1c Testing Market

Market Size Estimates: HbA1c testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: HbA1c testing market size by type, technology, end use, and region in terms of value ($B).

Regional Analysis: HbA1c testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, technologies, end uses, and regions for the HbA1c testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the HbA1c testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the HbA1c testing market size?

Answer: The global HbA1c testing market is expected to reach an estimated $3.4 billion by 2030.

Q2. What is the growth forecast for HbA1c testing market?

Answer: The global HbA1c testing market is expected to grow with a CAGR of 12.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the HbA1c testing market?

Answer: The major drivers for this market are growing incidence of diabetes and increasing awareness regarding glycemic control.

Q4. What are the major segments for HbA1c testing market?

Answer: The future of the HbA1c testing market looks promising with opportunities in the hospital &clinic, diagnostic laboratory, homecare, and research institution markets.

Q5. Who are the key HbA1c testing market companies?

Answer: Some of the key HbA1c testing companies are as follows.

• Abbott
• Bio-Rad Laboratories
• ARKRAY
• Danaher
• F. Hoffmann-La Roche

Q6. Which HbA1c testing market segment will be the largest in future?

Answer: Lucintel forecasts that turbidimetric inhibition immunoassay is expected to witness the highest growth over the forecast period as it delivers accurate results and are cost effective.

Q7. In HbA1c testing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increase in number of activities like esearch and awareness campaigns in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the HbA1c testing market by type (instruments, reagents, and kits), technology (ion exchange HPLC, enzymatic assay, affinity binding chromatography, turbidimetric inhibition immunoassay, and others), end use (hospitals and clinics, diagnostic laboratories, homecare, research institution, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global HbA1c Testing Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global HbA1c Testing Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global HbA1c Testing Market by Type
  • 3.3.1: Instruments
  • 3.3.2: Reagents
  • 3.3.3: Kits
• 3.4: Global HbA1c Testing Market by Technology
  • 3.4.1: Ion Exchange HPLC
  • 3.4.2: Enzymatic assay
  • 3.4.3: Affinity Binding Chromatography
  • 3.4.4: Turbidimetric Inhibition Immunoassay
  • 3.4.5: Others
• 3.5: Global HbA1c Testing Market by End Use
  • 3.5.1: Hospitals and Clinics
  • 3.5.2: Diagnostic Laboratories
  • 3.5.3: Homecare
  • 3.5.4: Research Institution
  • 3.5.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global HbA1c Testing Market by Region
• 4.2: North American HbA1c Testing Market
  • 4.2.1: North American HbA1c Testing Market by Technology: Ion Exchange HPLC, Enzymatic assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, and Others
  • 4.2.2: North American HbA1c Testing Market by End Use: Hospitals and Clinics, Diagnostic Laboratories, Homecare, Research Institution, and Others
• 4.3: European HbA1c Testing Market
  • 4.3.1: European HbA1c Testing Market by Technology: Ion Exchange HPLC, Enzymatic assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, and Others
  • 4.3.2: European HbA1c Testing Market by End Use: Hospitals and Clinics, Diagnostic Laboratories, Homecare, Research Institution, and Others
• 4.4: APAC HbA1c Testing Market
  • 4.4.1: APAC HbA1c Testing Market by Technology: Ion Exchange HPLC, Enzymatic assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, and Others
  • 4.4.2: APAC HbA1c Testing Market by End Use: Hospitals and Clinics, Diagnostic Laboratories, Homecare, Research Institution, and Others
• 4.5: ROW HbA1c Testing Market
  • 4.5.1: ROW HbA1c Testing Market by Technology: Ion Exchange HPLC, Enzymatic assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, and Others
  • 4.5.2: ROW HbA1c Testing Market by End Use: Hospitals and Clinics, Diagnostic Laboratories, Homecare, Research Institution, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global HbA1c Testing Market by Type
  • 6.1.2: Growth Opportunities for the Global HbA1c Testing Market by Technology
  • 6.1.3: Growth Opportunities for the Global HbA1c Testing Market by End Use
  • 6.1.4: Growth Opportunities for the Global HbA1c Testing Market by Region
• 6.2: Emerging Trends in the Global HbA1c Testing Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global HbA1c Testing Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global HbA1c Testing Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott
• 7.2: Bio-Rad Laboratories
• 7.3: ARKRAY
• 7.4: Danaher
• 7.5: F. Hoffmann-La Roche